BioAtla Statistics

Total Valuation

BioAtla has a market cap or net worth of $30.30 million. The enterprise value is -$1.27 million.

Market Cap	30.30M
Enterprise Value	-1.27M

Important Dates

The last earnings date was Tuesday, May 6, 2025, after market close.

Earnings Date	May 6, 2025
Ex-Dividend Date	n/a

Share Statistics

BioAtla has 58.42 million shares outstanding. The number of shares has increased by 6.70% in one year.

Current Share Class	58.42M
Shares Outstanding	58.42M
Shares Change (YoY)	+6.70%
Shares Change (QoQ)	+17.31%
Owned by Insiders (%)	10.69%
Owned by Institutions (%)	17.25%
Float	43.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.43
Forward PS	n/a
PB Ratio	55.82
P/TBV Ratio	55.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.35, with a Debt / Equity ratio of 1.01.

Current Ratio	2.35
Quick Ratio	2.02
Debt / Equity	1.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -246.21% and return on invested capital (ROIC) is -159.03%.

Return on Equity (ROE)	-246.21%
Return on Assets (ROA)	-65.79%
Return on Invested Capital (ROIC)	-159.03%
Return on Capital Employed (ROCE)	-301.11%
Revenue Per Employee	$180,328
Profits Per Employee	-$1.01M
Employee Count	61
Asset Turnover	0.17
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.14% in the last 52 weeks. The beta is 0.91, so BioAtla's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	-66.14%
50-Day Moving Average	0.40
200-Day Moving Average	1.03
Relative Strength Index (RSI)	68.36
Average Volume (20 Days)	466,302

Short Selling Information

The latest short interest is 4.34 million, so 7.42% of the outstanding shares have been sold short.

Short Interest	4.34M
Short Previous Month	4.30M
Short % of Shares Out	7.42%
Short % of Float	9.90%
Short Ratio (days to cover)	7.85

Income Statement

In the last 12 months, BioAtla had revenue of $11.00 million and -$61.88 million in losses. Loss per share was -$1.21.

Revenue	11.00M
Gross Profit	-45.60M
Operating Income	-67.10M
Pretax Income	-104.56M
Net Income	-61.88M
EBITDA	-66.23M
EBIT	-67.10M
Loss Per Share	-$1.21

Full Income Statement

Balance Sheet

The company has $32.36 million in cash and $554,000 in debt, giving a net cash position of $31.81 million or $0.54 per share.

Cash & Cash Equivalents	32.36M
Total Debt	554,000
Net Cash	31.81M
Net Cash Per Share	$0.54
Equity (Book Value)	547,000
Book Value Per Share	0.01
Working Capital	21.53M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-57.40M
Capital Expenditures	n/a
Free Cash Flow	-57.40M
FCF Per Share	-$0.98

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-610.00%
Pretax Margin	-562.51%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioAtla does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.70%
Shareholder Yield	-6.70%
Earnings Yield	-202.60%
FCF Yield	-187.93%

Analyst Forecast

The average price target for BioAtla is $1.00, which is 92.83% higher than the current price. The consensus rating is "Buy".

Price Target	$1.00
Price Target Difference	92.83%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	32.38%
EPS Growth Forecast (5Y)	-8.36%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioAtla has an Altman Z-Score of -21.94 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-21.94
Piotroski F-Score	1